TI
VIR icon

Trexquant Investment’s Vir Biotechnology VIR Stock Holding History

Trexquant Investment’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$849K Buy
+94,767
New +$755K 0.01% 1285
2025
Q3 		– Sell
-217,355
Closed -$1.1M – 1941
2025
Q2 		$1.1M Buy
+217,355
New +$1.17M 0.01% 1082
2024
Q4 		– Sell
-196,991
Closed -$1.48M – 1875
2024
Q3 		$1.48M Buy
196,991
+94,688
+93% +$822K 0.02% 914
2024
Q2 		$910K Buy
+102,303
New +$981K 0.01% 1030
2023
Q1 		– Sell
-39,885
Closed -$1.01M – 1799
2022
Q4 		$1.01M Sell
39,885
-66,915
-63% -$1.64M 0.03% 640
2022
Q3 		$2.06M Buy
106,800
+68,060
+176% +$1.73M 0.07% 351
2022
Q2 		$987K Buy
38,740
+23,514
+154% +$549K 0.04% 526
2022
Q1 		$392K Buy
+15,226
New +$452K 0.02% 883
2021
Q1 		– Sell
-18,678
Closed -$500K – 1499
2020
Q4 		$500K Buy
18,678
+5,103
+38% +$166K 0.05% 451
2020
Q3 		$466K Buy
+13,575
New +$584K 0.03% 723

Other funds holding VIR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
GP
GSK plc London $599M AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Trexquant Investment's VIR Position: Q1 2026 in Review

Trexquant Investment opened a new position in Vir Biotechnology (VIR) in Q1 2026: 94,767 shares worth $849K. The stake represents 0.01% of the portfolio and ranks #1285 among its holdings. This is a return to the name: Trexquant Investment previously reported a position in VIR as recently as Q2 2025.

Trexquant Investment first reported a position in VIR in Q3 2020 and has held it in 10 quarters since. The position peaked at $2.06M in Q3 2022. 251 funds tracked by Wall St. Rank hold VIR as of Q1 2026.

  • Trexquant Investment held 94,767 shares of Vir Biotechnology worth $849K as of Q1 2026.
  • Vir Biotechnology was a new Trexquant Investment position in Q1 2026.
  • Vir Biotechnology made up 0.01% of Trexquant Investment's portfolio in Q1 2026, its #1285 holding.
  • Trexquant Investment first reported a position in Vir Biotechnology in Q3 2020 and has held it in 10 quarters since.
  • Trexquant Investment's Vir Biotechnology position peaked at $2.06M in Q3 2022.
  • 251 funds tracked by Wall St. Rank held Vir Biotechnology as of Q1 2026.

Based on Trexquant Investment's 13F filing for Q1 2026, filed 15 May 2026.